About this trial
The aim of this study is to evaluate the responsiveness of the capsule endoscope to the attitude controller and to investigate its active locomotion performance within the small bowel.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients scheduled to undergo enteroscopy.
Disqualifiers
Patients with severe dysfunction of vital organs (e.g., heart, lungs). Patients with small bowel obstruction precluding adequate bowel preparation. Patients with a history of multiple abdominal surgeries. Patients with implanted devices such as cardiac pacemakers or metal implants. Patients with other high-risk conditions or lesions (e.g., moderate-to-severe esophagogastric varices, massive ascites).
Trial design
Single group
Treatments tested in this trial
magnetic control
DeviceIntervention: On the day of the examination, the subject will swallow the capsule endoscope. This will be followed by a standard enteroscopy procedure. During the routine air/water insufflation phases of the enteroscopy, the researchers will attempt to guide the capsule's movement using an external magnetic control device.
Treatment groups
Trial outcomes
Primary outcomes
capsule endoscope's responsiveness to the attitude controller
Excellent: The magnetically controlled capsule endoscope can precisely follow the attitude controller to move to the target area. Moderate: The magnetically controlled capsule endoscope can follow the attitude controller's movement, but cannot be accurately guided to the target area. Poor: There are signs of magnetic attraction, but the capsule does not follow the movement of the attitude controller.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Shandong University
Lead sponsor
Qilu Hospital of Shandong University
Sponsor institution